Related Experiment Video
Updated: Jul 6, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Beta2-microglobulin stimulates osteoclast formation.
C Menaa1, E Esser, S M Sprague
1Evanston Northwestern Healthcare and Northwestern University Feinberg School of Medicine, Evanston, Illinois 60201, USA.
Beta-2 microglobulin (beta(2)M) directly stimulates osteoclast activity, causing bone destruction in dialysis-related amyloidosis. This process involves cytokine production and is linked to chronic kidney disease complications.
Area of Science:
- Nephrology
- Bone Biology
- Immunology
Background:
- Dialysis-related amyloidosis (DRA) is a complication of long-term chronic kidney disease (CKD).
- DRA involves beta-2 microglobulin (beta(2)M) amyloid deposition in osteoarticular tissues, leading to arthropathy, bone cysts, and fractures.
- Osteolytic lesions are characteristic findings in DRA.
Purpose of the Study:
- To investigate if beta(2)M directly stimulates osteoclast activity.
- To determine if local cytokine production mediates beta(2)M-induced bone destruction.
- To elucidate the role of beta(2)M in the pathogenesis of bone complications in CKD.
Main Methods:
- Cultured mouse marrow cells, colony-forming unit granulocyte macrophages, and RAW 264.7 monocytic cells were treated with beta(2)M.
- Osteoclastogenesis was assessed by counting tartrate-resistant alkaline phosphatase-positive multinucleated cells.
- Cytokine expression (TNF-alpha, IL-1) was measured, and the effect of a TNF-alpha-neutralizing antibody was evaluated.
Main Results:
- Beta-2 microglobulin (beta(2)M) induced a dose-dependent increase in osteoclast formation.
- Osteoclastogenesis occurred independently of osteoblasts or stromal cells.
- Beta(2)M upregulated TNF-alpha and IL-1 expression, and TNF-alpha neutralization blocked beta(2)M-induced osteoclast formation.
Conclusions:
- Beta-2 microglobulin (beta(2)M) directly stimulates osteoclastogenesis.
- Tumor necrosis factor-alpha (TNF-alpha) mediates the osteoclastogenic effect of beta(2)M.
- These findings support a direct role for beta(2)M in causing bone destruction in dialysis-related amyloidosis and CKD.
Related Concept Videos
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Remodeling
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
